An update from Aziyo Biologics (ELUT) is now available.
Elutia Inc. announced that their new product, EluPro®, previously known as CanGaroo®RM, has received FDA clearance. This antibiotic-eluting bioenvelope represents a significant milestone for the company, potentially impacting its stock as it marks a major regulatory success. The announcement could signal a positive shift for investors and those tracking the pharmaceutical sector.
Learn more about ELUT stock on TipRanks’ Stock Analysis page.
